🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well talimogene laherparepvec works in trea...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2016-08-01
Trial ID
NCT02658812
Treatments Being Tested
This is a non-drug study in patients with Parkinson's Disease (PD) and heal...
Status
Completed
Location
Centre Hospitalo-Universitaire Grenoble Alpes
Start Date
2022-07-11
Trial ID
NCT05837130
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
Fondazione Istituto Nazionale dei Tumori
Start Date
2010-10
Trial ID
NCT01172912
Inflammatory synaptopathy is a prominent pathogenic mechanism in multiple s...
Status
Unknown
Location
IRCCS Neuromed
Start Date
2019-12-10
Trial ID
NCT03999788
This phase I trial studies the side effects and best dose of activated T-ce...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02470559
Treatments Being Tested
Drugs used in chemotherapy use different ways to stop cancer cells from div...
Status
Completed
Location
Johns Hopkins University
Start Date
2001-03
Trial ID
NCT00012376
Treatments Being Tested
This pilot clinical trial studies busulfan, melphalan, and stem cell transp...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2013-04-09
Trial ID
NCT01798004
Treatments Being Tested
This phase II trial is studying the side effects and how well decitabine wo...
Status
Completed
Location
UCSF Medical Center-Mount Zion
Start Date
2006-11-15
Trial ID
NCT00416598
This phase I/II trial studies the side effects and best dose of donor natur...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2014-05-19
Trial ID
NCT01787474
This phase I trial is studying the side effects and best dose of ipilimumab...
Status
Completed
Location
UCSF Medical Center-Mount Zion
Start Date
2003-05-13
Trial ID
NCT00064129
Treatments Being Tested